Analyst firms · Morgan Stanley · CLX

Morgan Stanley CLX price target and rating history

Clorox Company (CLX) · Consumer Discretionary

Morgan Stanley rates Clorox Company (CLX) Equal-Weight with a $130 price target, as of its latest action on Oct 17, 2022. It has published 4 rating actions on CLX since August 2021, including 1 upgrade and 0 downgrades.

Current rating
Equal-Weight
Price target
$130
Median target, all firms
Too few
Actions on CLX
4

Morgan Stanley price target on CLX

$160$145$13020222023202420252026
Morgan Stanley price target on CLX, each point a stated target, August 2021 to October 2022.

Every Morgan Stanley rating on CLX

How other firms rate CLX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Evercore ISIIn-line$99Nov 2, 2026
JefferiesHold$98Jul 28, 2026
BNP Paribas ExaneNeutralFeb 11, 2026

Questions about Morgan Stanley and CLX

What is Morgan Stanley's price target for CLX?
Morgan Stanley's latest stated price target for Clorox Company (CLX) is $130, from its action on Oct 17, 2022.
What is Morgan Stanley's rating on CLX?
Morgan Stanley rates CLX Equal-Weight, a neutral rating, as of Oct 17, 2022.
When did Morgan Stanley last change its view on CLX?
On Oct 17, 2022, Morgan Stanley upgrades to Equal-Weight from Underweight, price target $130.

More CLX rating histories

All Morgan Stanley ratingsCLX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.